Carisma Therapeutics Inc. Restructuring Charges
Carisma Therapeutics Inc. reported Restructuring Charges of $11.76 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2023-02-28
- Carisma Therapeutics Inc. restructuring charges for the quarter ending 2022-12-31 was $817.00K, a 13516.67% increase year-over-year.
- Carisma Therapeutics Inc. restructuring charges for the quarter ending 2022-09-30 was $10.95M, a 98.24% increase year-over-year.
- Carisma Therapeutics Inc. restructuring charges for the quarter ending 2021-12-31 was $6.00K.
- Carisma Therapeutics Inc. restructuring charges for the quarter ending 2021-09-30 was $5.52M.
- Carisma Therapeutics Inc. restructuring charges for fiscal 2022 was $11.76M, a 112.81% increase from fiscal 2021.
- Carisma Therapeutics Inc. restructuring charges for fiscal 2021 was $5.53M.
- Carisma Therapeutics Inc. restructuring charges for fiscal 2020 was $0.00.
- Carisma Therapeutics Inc. restructuring charges for fiscal 2019 was $0.00.
| Period end | Restructuring Charges | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $11.76M derived: sum of 2 quarters · filed 2023-02-28 | $11.76M 10-K · filed 2023-02-28 | ||
| 2022-09-30 | $10.95M 10-Q · filed 2022-11-07 | $10.95M 10-Q · filed 2022-11-07 | |||
| 2021-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.53M derived: sum of 2 quarters · filed 2023-02-28 | $5.53M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $5.52M 10-Q · filed 2022-11-07 | $5.52M 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | ||||
| 2018-12-31 | $0.00 10-K · filed 2019-03-01 | ||||
| 2017-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $170.00K 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $188.00K 10-Q · filed 2017-11-17 | ||||
| 2016-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$598.06K derived: sum of 2 quarters · filed 2017-03-24 | $1.94K derived: sum of 3 quarters · filed 2017-03-24 | $1.94K 10-K · filed 2017-03-24 | |
| 2016-09-30 | $1.30M 10-Q · filed 2016-11-14 | $1.90M derived: sum of 2 quarters · filed 2016-11-14 | $1.90M 10-Q · filed 2016-11-14 | ||
| 2016-09-20 | $1.30M 10-K · filed 2019-03-01 | ||||
| 2016-06-30 | $600.00K 10-Q · filed 2016-08-12 | $582.00K 10-Q · filed 2016-11-14 | |||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2017-03-24 | ||||
| 2013-12-31 | $279.00K 10-K · filed 2015-03-06 |